ALNYLAM PHARMACEUTICALS, INC. ($ALNY)
Fitzgerald Kevin Joseph โ CSO & EVP, Head of Research
Shares
2,041
Price
$331.96
Total Value
$677,531.58
Nearby Earnings
Feb 12, 2026
EPS:0.82 (est: 1.16)-29.3%
Revenue:$1.10B (est: $1.15B)-4.5%
Transaction Details
| Insider | Fitzgerald Kevin Joseph |
|---|---|
| Title | CSO & EVP, Head of Research |
| Transaction Date | Feb 17, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Feb 18, 2026 |
| Document Date | Feb 12, 2026 |
| Shares Sold | 2,041 |
| Price per Share | $331.96 |
| Total Value | $677,531.58 |
| Shares Owned After | 21,264 |
| Derivative | No |
| Accession Number | 0001735276-26-000026 |
| Document | View SEC Filing |